TOPLINEMore employers could cover popular weight loss and diabetes drugs like Ozempic and Wegovy in 2024, allowing workers to avoid steep out-of-pocket costs, a new survey found—though the drugs’ high costs have caused other workplaces to either stop coverage altogether or up monthly co-pays.KEY FACTSAround 43% of the 500 employers who participated in a new […]